Corvus Pharmaceuticals, Inc. (CRVS) vs Rigel Pharmaceuticals, Inc. (RIGL)
A side-by-side comparison of Corvus Pharmaceuticals, Inc. and Rigel Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CRVS
Corvus Pharmaceuticals, Inc.
$10.56HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
RIGL
Rigel Pharmaceuticals, Inc.
$46.11HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — CRVS vs RIGL
growth of $100 · dividends reinvested · last 10yCRVS -33.9% (-4.1%/yr)RIGL +30.2% (+2.7%/yr)RIGL compounded faster over this window
CRVS RIGL
CRVS vs RIGL: by the numbers
- •CRVS is the larger company ($888M vs $853M market cap).
- •RIGL is profitable (116.30% net margin) while CRVS runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | CRVS | RIGL |
|---|---|---|
| P/E ratio | N/A | 2.83 |
| Forward P/E | N/A | 13.44 |
| P/S ratio | N/A | 3.08 |
| P/B ratio | 3.94 | 2.01 |
| EV / EBITDA | N/A | 9.28 |
| FCF yield | N/A | 9.31% |
Profitability
| Metric | CRVS | RIGL |
|---|---|---|
| Gross margin | 0.00% | 91.39% |
| Operating margin | 0.00% | 42.63% |
| Net margin | 0.00% | 116.30% |
| ROE | -24.02% | 75.67% |
| ROIC | -25.25% | 18.72% |
Growth (annualized)
| Metric | CRVS | RIGL |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 13.94% |
| Total return CAGR (5Y) | 17.88% | 6.25% |
Frequently asked
- Is CRVS or RIGL more profitable?
- RIGL runs the higher net margin — CRVS at 0.00% versus RIGL at 116.30%.
- How have CRVS and RIGL total returns compared?
- Over the past 10 years, CRVS delivered -4.26% and RIGL delivered 1.77% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Rigel Pharmaceuticals P/E ratioCorvus Pharmaceuticals ROERigel Pharmaceuticals ROECorvus Pharmaceuticals operating marginRigel Pharmaceuticals operating marginCorvus Pharmaceuticals revenue growthRigel Pharmaceuticals revenue growthCorvus Pharmaceuticals free cash flowRigel Pharmaceuticals free cash flow
Corvus Pharmaceuticals & Rigel Pharmaceuticals appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.